Drug Profile
GK 664S
Alternative Names: GK664SLatest Information Update: 17 Jan 2022
Price :
$50
*
At a glance
- Originator Maruho
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Eczema; Plaque psoriasis
Most Recent Events
- 30 Sep 2019 Discontinued - Phase-III for Plaque psoriasis in Japan (Topical)
- 01 May 2016 Maruho completes a phase III trial in Plaque psoriasis in Japan (JapicCTI152858)
- 01 Jan 2015 Phase-III clinical trials in Plaque psoriasis in Japan (Topical) (JapicCTI152858)